A Final LDT Rule in April!? Will FDA be prepared?
FDA Law Blog: Biosimilars
DECEMBER 11, 2023
1] Yet FDA’s conclusions about the Agency’s ability to regulate the entire laboratory industry are based on fundamentally flawed assumptions about the number of entities and tests that will be subject to FDA regulation. 5] This stratification, though, assumes that LDTs will follow the same pattern as IVDs currently regulated by FDA.
Let's personalize your content